Skip to main content

Table 3 Responses to neo-adjuvant chemotherapy regimens in 174 pre-mastectomy patients in Surgical Oncology Division, UCH Ibadan in 1999-2009

From: Mastectomy for management of breast cancer in Ibadan, Nigeria

 

Complete response

Partial response

Stable disease

Disease progression

Total (%)

AC

34 (18.8%)

29 (16.9%)

16 (9.5%)

7 (4.1%)

86 (49.3)

CAF

16 (8.8%)

11 (6.5%)

11 (6.5%)

6 (3.5%)

44 (25.3)

CMF

4 (2.3%)

5 (2.9%)

-

2 (1.2%)

11 (6.4)

Others.

9 (5.0%)

11 (6.5%)

5 (2.9%)

8 (4.6%)

33 (19.0)

Total (%)

63 (34.9%)

56 (32.8%)

32 (18.9%)

23 (13.4%)

174 (100)

  1. A, Adriamycin; C, Cyclophosphamide; F, 5-Fluorouracil; M, Methotrexate.